These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 8877713)

  • 41. Polymorphic Sirpa is the genetic determinant for NOD-based mouse lines to achieve efficient human cell engraftment.
    Yamauchi T; Takenaka K; Urata S; Shima T; Kikushige Y; Tokuyama T; Iwamoto C; Nishihara M; Iwasaki H; Miyamoto T; Honma N; Nakao M; Matozaki T; Akashi K
    Blood; 2013 Feb; 121(8):1316-25. PubMed ID: 23293079
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Selective purging of human multiple myeloma cells from autologous stem cell transplantation grafts using oncolytic myxoma virus.
    Bartee E; Chan WM; Moreb JS; Cogle CR; McFadden G
    Biol Blood Marrow Transplant; 2012 Oct; 18(10):1540-51. PubMed ID: 22516053
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [The immuno-deficient mice transplantion models in study of human hematopoietic stem cells--review].
    Hu D; Huang SA
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2004 Dec; 12(6):875-9. PubMed ID: 15631683
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Immune-deficient mouse models for analysis of human stem cells.
    Meyerrose TE; Herrbrich P; Hess DA; Nolta JA
    Biotechniques; 2003 Dec; 35(6):1262-72. PubMed ID: 14682062
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Immunodeficient mice xenografted with human lymphoid cells: new models for in vivo studies of human immunobiology and infectious diseases.
    Mosier DE
    J Clin Immunol; 1990 Jul; 10(4):185-91. PubMed ID: 1976649
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Hematological Humanization of Immune-Deficient Mice.
    Gergues M; Ayer S; Morelli S; Greco SJ; Rameshwar P
    Methods Mol Biol; 2021; 2224():195-202. PubMed ID: 33606216
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Establishment of a rhabdomyosarcoma xenograft model in human-adapted mice.
    Seitz G; Pfeiffer M; Fuchs J; Warmann SW; Leuschner I; Vokuhl C; Lang P; Handgretinger R; Armeanu-Ebinger S
    Oncol Rep; 2010 Oct; 24(4):1067-72. PubMed ID: 20811690
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Possible role of preformed natural antibodies in preventing bone marrow engraftment in a discordant xenogeneic species combination (human-to-mouse).
    Kong SS; Ricordi C; Inverardi L
    Transplant Proc; 1997 Jun; 29(4):2069-70. PubMed ID: 9193531
    [No Abstract]   [Full Text] [Related]  

  • 49. In utero transplantation of hematopoietic stem cells.
    Flake AW; Zanjani ED
    Crit Rev Oncol Hematol; 1993 Aug; 15(1):35-48. PubMed ID: 7902097
    [No Abstract]   [Full Text] [Related]  

  • 50. Chiaroscuro hematopoietic stem cell.
    Quesenberry P; Habibian M; Dooner M; Zhong S; Reilly J; Peters S; Becker P; Grimaldi C; Carlson J; Reddy P; Nilsson S; Stewart FM
    Trans Am Clin Climatol Assoc; 1998; 109():19-25; discussion 25-6. PubMed ID: 9601124
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Quantitative evaluation of the immunodeficiency of a mouse strain by tumor engraftments.
    Ye W; Jiang Z; Li GX; Xiao Y; Lin S; Lai Y; Wang S; Li B; Jia B; Li Y; Huang ZL; Li J; Feng F; Li S; Yao H; Liu Z; Cao S; Xu L; Li Y; Wu D; Zeng L; Zhong M; Liu P; Wen ZS; Xu B; Yao Y; Pei D; Li P
    J Hematol Oncol; 2015 May; 8():59. PubMed ID: 26022250
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Immunobiology of bone marrow transplantation: studies using scid mice.
    Murphy WJ; Kumar V; Bennett M
    Curr Top Microbiol Immunol; 1989; 152():251-8. PubMed ID: 2805793
    [No Abstract]   [Full Text] [Related]  

  • 53. Developmentally-faithful and effective human erythropoiesis in immunodeficient and Kit mutant mice.
    Fiorini C; Abdulhay NJ; McFarland SK; Munschauer M; Ulirsch JC; Chiarle R; Sankaran VG
    Am J Hematol; 2017 Sep; 92(9):E513-E519. PubMed ID: 28568895
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Intramuscular Transplantation Improves Engraftment Rates for Esophageal Patient-Derived Tumor Xenografts.
    Read M; Liu D; Duong CP; Cullinane C; Murray WK; Fennell CM; Shortt J; Westerman D; Burton P; Clemons NJ; Phillips WA
    Ann Surg Oncol; 2016 Jan; 23(1):305-11. PubMed ID: 25691278
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effect of immunosuppressive therapy on cytolytic activity of immunodeficient mice: implications for xenogeneic transplantation.
    Cavacini LA; Giles-Komar J; Kennel M; Quinn A
    Cell Immunol; 1992 Oct; 144(2):296-310. PubMed ID: 1394445
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Immune-deficient mice as models for human hematopoietic disease.
    Dick JE
    Mol Genet Med; 1991; 1():77-115. PubMed ID: 1688188
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Establishing humanized mice using stem cells: maximizing the potential.
    Bernard D; Peakman M; Hayday AC
    Clin Exp Immunol; 2008 Jun; 152(3):406-14. PubMed ID: 18435804
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Zebrafish Xenografts for the In Vivo Analysis of Healthy and Malignant Human Hematopoietic Cells.
    Konantz M; Müller JS; Lengerke C
    Methods Mol Biol; 2019; 2017():205-217. PubMed ID: 31197779
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Quantitative tools for assessing the fate of xenotransplanted human stem/progenitor cells in chimeric mice.
    Cheng K; Gupta S
    Xenotransplantation; 2009; 16(3):145-51. PubMed ID: 19566654
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cancer stem cells--perspectives on current status and future directions: AACR Workshop on cancer stem cells.
    Clarke MF; Dick JE; Dirks PB; Eaves CJ; Jamieson CH; Jones DL; Visvader J; Weissman IL; Wahl GM
    Cancer Res; 2006 Oct; 66(19):9339-44. PubMed ID: 16990346
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.